LICENSE AGREEMENTLicense Agreement • November 13th, 2017 • Marina Biotech, Inc. • Pharmaceutical preparations • Delaware
This LICENSE AGREEMENT (this “Agreement”) is made and entered into this 17th day of July, 2017 (the “Effective Date”) by and between Marina Biotech, Inc. (formerly known as MDRNA, Inc.), a Delaware corporation (“Marina”), and Oncotelic, Inc., a Delaware corporation, (“Oncotelic”).
MARINA BIOTECH, INC. 17870 Castleton Street, Suite 250 City of Industry, California 91748Letter Agreement • November 13th, 2017 • Marina Biotech, Inc. • Pharmaceutical preparations • New York
Reference is hereby made to that certain letter agreement dated July 3, 2017 (the “Letter Agreement”) between and among Marina Biotech, Inc. (the “Company”), EOS Holdings LLC (“EOS”) and Peak Capital Advisory Limited (“Peak” and, together with EOS, the “Purchasers”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Letter Agreement (or the agreements and instruments that were referenced therein or amended thereby, as applicable).
